Multiples Alternate Asset Management, a private equity (PE) fund led by Renuka Ramnath, is all set to invest around INR 750 crores (USD 100 million) for getting 10% stake in Mumbai-based generic drugs manufacturer, BDR

Molecular Partners AG (MOLN), a clinical-stage biotech company delivering unique therapies to people with cancer and other serious diseases, has recently announced entering into a license agreement with Novartis AG (NV

MicroPort CRM, a firm that manufactures, develops, and markets products for the analysis, treatment & management of heart rhythm disorders and heart failures, has recently received an approval from the PMDA Japanes

SNIPR BIOME ApS, the CRISPR and microbiome company, has recently announced that the US Food & Drug Administration has approved the Investigational New Drug (IND) Application for its first development candidate, emp

The research report on Idiopathic Pulmonary Fibrosis Disease Treatment market includes data on crucial aspects like growth stimulants, challenges, and prospects that are likely to influence the expansion graph of the industry.

The “ OTC Anti-Infective Drug Market” report offers a detailed study on the evaluation of industry with respect to competitive players, latest advancements, regional analysis, emerging trends, and current tendencies of the end-user. T

The Personal Emergency Response Service market report highlights the significant growth drivers, opportunities, and challenges that are slated to define the growth trajectory of this business space in the ensuing years. According to the d

Lucentis Market report provides in-depth statistics and analysis available on the market status of the Lucentis Market Manufacturers and is a valuable method of obtaining guidance and direction for companies and business enterprise insider con

The G-quadruplex (G4) Antibody market report is an exhaustive investigation of this business sphere. The report predicts the market renumeration and growth rate over the estimated timeframe. It expounds the vitals of G-quadruplex (G4) Antibody